Captopril - Revision history

Kfarzam: /* Pharmacology */

2022-08-20T05:39:25Z

Pharmacology

← Revisión anterior		Revisión del 05:39 20 ago 2022
Línea 33:		Línea 33:
	*Metabolism: Hepatic		*Metabolism: Hepatic
	*Excretion: Renal, dialzable		*Excretion: Renal, dialzable
			*Rapid onset

	==Mechanism of Action==		==Mechanism of Action==

Elcatracho: /* See Also */

2021-03-08T15:54:20Z

ClaireLewis at 21:43, 19 September 2019

2019-09-19T21:43:27Z

← Revisión anterior		Revisión del 21:43 19 sep 2019
Línea 42:		Línea 42:
	==References==		==References==
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:Cardiology]]

Humanguy: /* Pharmacology */ edited metabolism

2017-10-12T00:17:09Z

Pharmacology: edited metabolism

← Revisión anterior		Revisión del 00:17 12 oct 2017
Línea 31:		Línea 31:
	==Pharmacology==		==Pharmacology==
	*Half-life: < 3 hours		*Half-life: < 3 hours
	*Metabolism:		*Metabolism: Hepatic
	*Excretion: Renal, dialzable		*Excretion: Renal, dialzable

Humanguy: /* Administration */ edited dosage forms, strengths, routes of administration

2017-10-12T00:16:11Z

Administration: edited dosage forms, strengths, routes of administration

← Revisión anterior		Revisión del 00:16 12 oct 2017
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: [[ACE inhibitor]]		*Type: [[ACE inhibitor]]
	*Dosage Forms:		*Dosage Forms: tablet
	*Routes of Administration: ~~Oral~~		*Dosage Strengths: 12.5, 25, 50, 100mg
	*Common Trade Names:		*Routes of Administration: PO
			*Common Trade Names: Capoten, Captoril

	==Adult Dosing==		==Adult Dosing==

Mholtz: Text replacement - "-->" to "→"

2017-02-08T19:50:25Z

Text replacement - "-->" to "→"

← Revisión anterior		Revisión del 19:50 8 feb 2017
Línea 34:		Línea 34:

	==Mechanism of Action==		==Mechanism of Action==
	*Inhibits angiotensin I-converting enzyme, blocks conversion of angiotensin ~~I-->~~ angiotensin II		*Inhibits angiotensin I-converting enzyme, blocks conversion of angiotensin I→ angiotensin II
	==Comments==		==Comments==

Rossdonaldson1: Text replacement - "Hyperkalemia" to "Hyperkalemia"

2016-09-24T15:42:06Z

Text replacement - "*Hyperkalemia" to "*Hyperkalemia"

← Revisión anterior		Revisión del 15:42 24 sep 2016
Línea 25:		Línea 25:
	===Common===		===Common===
	*Hypotension		*Hypotension
	*Hyperkalemia		*[[Hyperkalemia]]
	*Cough		*Cough
	*Rash		*Rash

ClaireLewis: /* Administration */

2016-09-08T15:52:51Z

Administration

← Revisión anterior		Revisión del 15:52 8 sep 2016
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: [[ACE-inhibitor]]		*Type: [[ACE inhibitor]]
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration: Oral		*Routes of Administration: Oral
	*Common Trade Names:		*Common Trade Names:

	==Adult Dosing==		==Adult Dosing==

ClaireLewis: Created page with "==Administration== Type: ACE-inhibitor Dosage Forms: Routes of Administration: Oral Common Trade Names: ==Adult Dosing== *6.25-150mg PO three times per day ==Pediatr..."

2016-09-08T15:51:06Z

Created page with "==Administration== *Type: ACE-inhibitor *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult Dosing== *6.25-150mg PO three times per day ==Pediatr..."

Página nueva

==Administration==
*Type: [[ACE-inhibitor]]
*Dosage Forms:
*Routes of Administration: Oral
*Common Trade Names:

==Adult Dosing==
*6.25-150mg PO three times per day
==Pediatric Dosing==
''Safety/efficacy not established in pediatric patients''
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: D
*[[Lactation risk categories|Lactation risk]]: Infant risk minimal
*Renal dosing: Initial dose should be reduced, titrate in smaller increments

==Contraindications==
*Allergy to class/drug
*History of ACE-inhibitor induced angioedema

==Adverse Reactions==
===Serious===
*Angioedema
*Stevens-Johnson syndrome
*Agranulocytosis, neutropenia
===Common===
*Hypotension
*Hyperkalemia
*Cough
*Rash
==Pharmacology==
*Half-life: < 3 hours
*Metabolism:
*Excretion: Renal, dialzable

==Mechanism of Action==
*Inhibits angiotensin I-converting enzyme, blocks conversion of angiotensin I--> angiotensin II
==Comments==

==See Also==
*[[ACE-inhibitors]]
==References==
<references/>
[[Category:Pharmacology]]

← Revisión anterior		Revisión del 15:54 8 mar 2021
Línea 39:		Línea 39:

	==See Also==		==See Also==
			*[[Hypertension]]
	*[[ACE-inhibitors]]		*[[ACE-inhibitors]]

	==References==		==References==
	<references/>		<references/>
	[[Category:Pharmacology]] [[Category:Cardiology]]		[[Category:Pharmacology]] [[Category:Cardiology]]